ITEMS IN AFP WITH KEYWORD:

Liver Disorders

Sep 01, 2021 Issue
Hereditary Hemochromatosis: Rapid Evidence Review [Article]

Hereditary hemochromatosis is an autosomal recessive disorder that disrupts iron homeostasis, resulting in systemic iron overload. It is the most common inherited disorder among people of northern European ancestry. Despite the high prevalence of the gene mutation, there is a low and variable clinic...


Sep 01, 2021 Issue
Chronic Musculoskeletal Pain, NAFLD, Peripheral Neuropathy, Myocardial Infarction [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.


Nov 15, 2020 Issue
Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management [Article]

Initial evaluation of nonalcoholic fatty liver disease includes excluding other possible causes of hepatic steatosis such as alcohol or hepatotoxic medication use. Noninvasive tests such as a clinical decision aid or elastography can be used to determine the likelihood of fibrosis and guide further evaluation. Weight loss through diet and exercise is the primary treatment. Comorbidities should also be managed.


Jan 1, 2020 Issue
Branched-chain Amino Acids for Patients with Hepatic Encephalopathy [Medicine by the Numbers]

Hepatic encephalopathy is a brain dysfunction that can be mild with minimal confusion, or overt and severe with coma. Learn more about branched-chain amino acids for the treatment of hepatic encephalopathy.


Dec 15, 2019 Issue
Cirrhosis: Diagnosis and Management [Article]

Cirrhosis is the 12th leading cause of death in the United States. New research shows that in early stages, it may be reversible. The most common causes are viral hepatitis, alcoholic liver disease, and nonalcoholic steatohepatitis. Most patients are asymptomatic until decompensation onset; evaluation should begin when symptoms appear. Noninvasive tests are most useful in identifying patients. Management includes counseling, laboratory testing, and ultrasound monitoring.


Feb 15, 2019 Issue
Metformin for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis [FPIN's Clinical Inquiries]

Metformin does not seem to be an effective treatment for nonalcoholic steatohepatitis. There are no studies evaluating whether metformin improves long-term patient-oriented outcomes such as progression from NAFLD to nonalcoholic steatohepatitis, cirrhosis, hepatocellular carcinoma, or death from liver failure.


Dec 1, 2017 Issue
Mildly Elevated Liver Transaminase Levels: Causes and Evaluation [Article]

Mild, asymptomatic elevations in transaminase levels are common in primary care. Nonalcoholic fatty liver disease is the most common cause and is often benign and treated with lifestyle modification. Learn about this and other less common causes of transaminase elevations.


Jun 15, 2017 Issue
Nonalcoholic Fatty Liver Disease: Identifying Patients at Risk of Inflammation or Fibrosis [Point-of-Care Guides]

NAFLD is defined as hepatic steatosis on imaging or histology in the absence of other etiologies for secondary fat accumulation. It is usually identified during the evaluation of elevated transaminase levels in a patient without heavy alcohol intake, or found incidentally on imaging studies.


May 1, 2017 Issue
Antibiotic Prophylaxis in Patients with Cirrhosis and Upper Gastrointestinal Bleeding [FPIN's Help Desk Answers]

Antibiotics should be used for prophylaxis in hospitalized patients with cirrhosis and upper gastrointestinal bleeding. Prophylaxis reduces all-cause mortality by 21%, as well as bacterial infections and rebleeding.


Feb 1, 2017 Issue
Evaluation of Jaundice in Adults [Article]

Jaundice can indicate significant underlying disease. Review key components of the history, physical examination, laboratory evaluation, and imaging tests to determine the cause.


Pages: 1 2 3 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now